Our study reported that BRAF (V600E) mutated NMs have a higher number of CNMs at the periphery of the mass, suggesting that the accumulation of genetic mutations in tumor cells could promote the creation of clones of cells that can aggregate and migrate by invading the dermis. This evidence concerns the gene BRAF and neuroleptic malignant syndrome.